Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-007619
Filing Date
2019-11-18
Accepted
2019-11-18 08:46:23
Documents
2
Period of Report
2019-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_111819.htm 6-K 5004
2 PRESS RELEASE exh_991.htm EX-99.1 16662
  Complete submission text file 0001171843-19-007619.txt   22670
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 191226281
SIC: 2834 Pharmaceutical Preparations